News | Remington Davis

Category:

All Categories

The Promise and Limits of AI Clinical Trial Recruitment

Oct 28th, 2025 in Trends

In the past year, Cleveland Clinic has made headlines for its strategic adoption of artificial intelligence across multiple areas of care and operations, from AI-powered structural heart tools through DASI Simulations to AI-driven revenue cycle management via AKASA. But another[...]

The Five-Star Experience: Setting a New Standard for Patient-Centricity in Clinical Trials

Aug 12th, 2025 in Trends

Participating in a clinical trial is a big commitment. It’s a decision that often requires patients to rearrange their work schedules, find transportation, fast before appointments, or spend hours away from home, all while navigating unknowns common to treatment and research. [...]

FDA Job Cuts Could Disrupt Clinical Trials

Jul 24th, 2025 in Trends

Over the past several months, the Food and Drug Administration (FDA) has seen a wave of high-level departures and widespread staff reductions — part of a broader government effort to reduce the Department of Health and Human Services (HHS) workforce by 10,000 jobs. In April of[...]

What Private Equity’s Rise in Clinical Research Means for Sites, Sponsors and Trial Outcomes

Jul 9th, 2025 in Trends

There has been a sharp uptick in recent years in private equity acquisitions of locally owned research sites. Backed by goals for greater scale and operational efficiency, these firms are assembling site networks that span geographies and specialties. But as this trend[...]

In the Age of AI, Patient-Centric Clinical Trials Must Stay Human at Heart

Jun 24th, 2025 in Trends

The future of clinical research is arriving faster than we imagined. With artificial intelligence now at the center of conversations between OpenAI and the FDA, the industry is on the cusp of a major transformation. There’s growing excitement about how AI could streamline drug[...]

The Rise of Rare Disease Clinical Trials: Trends, Challenges and What Sites Are Learning

Jun 4th, 2025 in Trends

Rare diseases may affect only small pockets of the population, but in clinical research, they make an outsized impact. In fact, 45% of global trial starts in 2024 were focused on rare diseases, according to theIQVIA Global R&D Trends report. Once considered too specialized or[...]

From Compliance to Connection: Community Engagement For Clinical Trials

Apr 24th, 2025 in Trends

As pressure grows for clinical research to be more representative, one thing is becoming increasingly clear: true inclusion doesn't start with recruitment goals, but rather relationships. In the latestSite Landscape Surveyfrom the Society for Clinical Research Sites (SCRS),[...]

AI in Clinical Trials: Can It Move the Needle Faster?

Jan 7th, 2025 in Trends

Clinical trials have a median cost of $19 million, with the average cost exceeding $41 million per trial. Considering the majority of trials face delays—and these can cost anywhere from hundreds of thousands to millions of dollars per day—there’s no shortage of incentive to[...]

How the Clinical Research Staffing Model Is Evolving

Dec 11th, 2024 in Trends

Traditionally, many professionals fell into clinical research by chance, starting at entry-level positions in the field and gradually progressing through the ranks. Now, we’re seeing a shift to a more intentional approach, where four-year bachelor degrees in clinical research[...]

Trends: